COMMUNIQUÉS West-GlobeNewswire

SupplyCopia to Showcase Enhanced AI Healthcare Solutions at AHRMM25
30/07/2025
Demonstrating Groundbreaking AI Smart Agent "Ask The BEE," Designed to Optimize Healthcare Supply Chain Analytics BRIDGEWATER, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- SupplyCopia, a leader in AI-driven healthcare supply [...]
Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025
30/07/2025
TOKYO and CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: [...]
La Fondation de la famille Slaight verse un don à la Croix-Rouge canadienne en soutien à ses programmes d’aide d’urgence
30/07/2025
Elle versera un million de dollars en soutien à des activités humanitaires essentielles à Cox’s Bazar, au Bangladesh OTTAWA, Ontario, 30 juill. 2025 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne tient à exprimer sa [...]
The Slaight Family Foundation announces Red Cross as part of its emergency support funding
30/07/2025
$1 million dollars will support critical humanitarian efforts in Cox’s Bazar, Bangladesh OTTAWA, Ontario, July 30, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross extends its gratitude to Gary Slaight and The Slaight [...]
Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision
30/07/2025
WARREN, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today highlighted the Company’s significant insider ownership of outstanding common stock, as most [...]
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products
30/07/2025
DURHAM, N.C., July 30, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, announced today a significant milestone with the U.S. Food and Drug Administration (FDA) [...]
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025
30/07/2025
BOSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer [...]
BriaCell Awarded New Zealand Patent for its Whole Cell Technology
30/07/2025
PHILADELPHIA and VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company [...]
Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress
30/07/2025
NORWOOD, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, announced today that an abstract on updated clinical data [...]
LENZ Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
30/07/2025
New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025 88-member sales force hired and prepared to initiate sales and marketing activities immediately [...]
Kane Biotech Showcases revyve™ Preclinical and Clinical Case Study Findings at North American Wound Care Conferences
30/07/2025
Clinical case series showed clinically meaningful reductions in wound size and pain, and improved tissue regranulation in chronic wound patients using revyve ® over 6–12 weeks Preclinical in vitro studies demonstrated [...]
Bionano Recaps Momentum behind Optical Genome Mapping at the Biennial Meeting of the European Cytogenomics Association Held Recently in Leuven, Belgium
30/07/2025
SAN DIEGO, July 30, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) recently participated in the European Cytogenomics Conference, which is the biennial meeting of the European Cytogenomics Association ( [...]
Paragon Genomics and Genecast Announce Global Partnership to Advance Precision Oncology
30/07/2025
Leaders in pioneering cancer diagnostics and NGS target enrichment technologies join forces to accelerate access to advanced molecular diagnostics for cancer FREMONT, Calif. and TAIZHOU, China, July 30, 2025 (GLOBE [...]
ORYZON Reports Financial Results and Corporate Update for Half-Year Ending June 30, 2025
30/07/2025
Between December 2024 and July 2025, Oryzon secured financing totaling €52 M, approx. $61 M (€30.0 M from a capital increase, €7.0 M from commercial bank loans, €13.2 M from the EU-IPCEI grant, and €1.8 M from R&D [...]
Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy
30/07/2025
BERKELEY, Calif, July 30, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the [...]
Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics
30/07/2025
• Allen Institute to employ Iterative Mapping, Nautilus’ single-molecule proteomics method, to investigate connection between tau protein and Alzheimer’s disease • Agreement links the organizations’ next-generation [...]
Valitor Highlights Three-fold Increase with VLTR-559 in Sustained Potency and Durability over Aflibercept in Preclinical Ocular Wet AMD Models
30/07/2025
-Data showcased in session titled “Spotlight on Drug Delivery” at the Ophthalmology Innovation Source (OIS) Retina 8 th Annual Innovation Summit -VLTR-559, a long-acting anti-VEGF therapy, could reduce dosing frequency [...]
BrainsWay to Report Second Quarter 2025 Financial Results on August 13, 2025
30/07/2025
BURLINGTON, Mass. and JERUSALEM, July 30, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental [...]
MIMEDX Announces Strategic Collaboration with Vaporox, Inc.
30/07/2025
Relationship Establishes Co-Promotion and Co-Marketing of MIMEDX’s Leading Placental Allograft Portfolio and Vaporox’s Vaporous Hyperoxia Treatment Device MARIETTA, Ga., July 30, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, [...]

Pages